Form 4: Veracyte Officer's Tax Withholding on RSU Vesting

Veracyte's VP, Chief Accounting Officer, Jonathan Wygant, reported the withholding of 1,325 common shares for tax obligations related to restricted stock unit vesting.

Summary

• Jonathan Wygant, Veracyte's VP, Chief Accounting Officer, reported a transaction on December 2, 2025.
• 1,325 shares of Veracyte common stock were disposed of at a price of $46.16 per share.
• This disposition was due to shares being withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
• This transaction does not represent a discretionary sale by the reporting person.
• Following this transaction, Jonathan Wygant beneficially owns 37,420 shares of Veracyte common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes related to RSU vesting, which is a common occurrence for executives. It does not indicate a change in sentiment towards the company by the officer.

Positives

• The transaction is a routine tax withholding event, not a discretionary sale by the officer, indicating continued holding of a significant number of shares.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax withholding, not a discretionary sale. The officer retains a significant stake.
• Employees: No direct impact.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary tax withholding event related to RSU vesting by a company officer. It does not signal any change in the officer's investment thesis or the company's fundamentals. Therefore, it provides no new information to warrant a change in investment recommendation; a 'hold' stance is maintained based solely on this filing.

Keywords

Veracyte, VCYT, Jonathan Wygant, Form 4, Insider Transaction, Tax Withholding, Restricted Stock Units, RSU Vesting, Officer Stock